Abstract: A unit commitment problem is solved for a set of generators with a set of configurations having a set of 2N.T schedules, wherein N is a number of generators i and T is a number of decision time steps. A reduced set of configurations is determined, and then a functional metric to measure a similarity of all possible pairs of the configurations is defined. Dynamic programming is applied to the reduced set of configurations using the similarity metric to determine an optimal configuration.

Abstract: An output of a photovoltaic (PV) device is predicted by applying Fourier analysis to historical data to obtain frequencies and a mean of the frequencies in the data. Regression analysis is applied to the data to obtain a regression coefficient. Then, the prediction is a sum of the mean at the time step and a deviation from the mean at a previous time step, wherein the means are represented and approximated by selected frequencies, and the deviation for the previous time step is weighted by the regression coefficient.

Abstract: A display includes an upper surface adapted to present visual information to a device user and an outer perimeter proximate the upper surface. An optically transparent lens is carried by a housing and overlies the display. The optically transparent lens and the upper portion of the housing together define an upper surface of the portable electronic device. An optically transparent resin is carried between the display and the optically transparent lens. The optically transparent resin includes a perimeter portion disposed between the outer perimeter of the display and the side portion of the housing. The resin can be cured using light.

Abstract: This invention relates to 5-substituted isoindoline compounds, and pharmaceutically acceptable salts, solvates, stereoisomers, and prodrugs thereof. Methods of use, and pharmaceutical compositions of these compounds are disclosed.

Abstract: The present invention relates to the field of medicine. Provided herein are aminoquinazoline derivatives, their salts and pharmaceutical formulations useful in modulating the protein tyrosine kinase activity, and in modulating inter- and/or intra-cellular signaling. Also provided herein are pharmaceutically acceptable compositions comprising the aminoquinazoline compounds and methods of using the compositions in the treatment of hyperproliferative disorders in mammals, especially humans.

Abstract: A display includes an encapsulation layer and a substrate. The substrate includes a chip on glass (COG) seat and a flexible printed circuit (FPC) connector seat. The COG seat and the FPC seats are positioned on different edges of the substrate. A cross-connection layer between the substrate layer and the encapsulation layer, the cross-connection layer including traces connected between the COG seat and the FPC seat. A device incorporating the display may take advantage of the symmetrical display to achieve new designs.

Abstract: A display device (301) includes a plurality of pixels (302,309,310,315,330,331,332) operable to emit or modulate light. Each pixel of the plurality of pixels comprising a plurality of subpixels (303,304,305,306,307,308,311,312,313,333,334,335). To create an asymmetrical spacing across the display module, every pixel can at least two subpixels spaced apart from each other by a predetermined distance (336), while one or more pixels, which form a subportion of the plurality of pixels, each comprise at least one subpixel spaced apart from at least one adjacent subpixel by another predetermined distance (337), where the other predefined spacing is greater than the predefined spacing.

Abstract: Provided are 4?-arylmethoxy isoindoline compounds, and pharmaceutically acceptable salts, solvates, clathrates, stereoisomers, and prodrugs thereof. Methods of use, and pharmaceutical compositions of these compounds are disclosed.

Abstract: An optimal conditional operational schedule for a set of power generators is determined by constructing states and transitions of a factored Markov decision process (fMDP) from a target electrical demand and generator variables. A cost function for the fMDP is constructed based on the electrical demand, the generator variables, and a risk coefficient. Then, the fMDP is solved to obtain the optimal conditional operational schedule.

Abstract: An output of a photovoltaic (PV) device is predicted by applying Fourier analysis to historical data to obtain frequencies and a mean of the frequencies in the data. Regression analysis is applied to the data to obtain a regression coefficient. Then, the prediction is a sum of the mean at the time step and a deviation from the mean at a previous time step, wherein the means are represented and approximated by selected frequencies, and the deviation for the previous time step is weighted by the regression coefficient.

Abstract: Provided are 4?-arylmethoxy isoindoline compounds, and pharmaceutically acceptable salts, solvates, clathrates, stereoisomers, and prodrugs thereof. Methods of use, and pharmaceutical compositions of these compounds are disclosed.

Abstract: A unit commitment problem is solved for a set of generators with a set of configurations having a set of 2N.T schedules, wherein N is a number of generators i and T is a number of decision time steps. A reduced set of configurations is determined, and then a functional metric to measure a similarity of all possible pairs of the configurations is defined. Dynamic programming is applied to the reduced set of configurations using the similarity metric to determine an optimal configuration.

Abstract: The invention encompasses novel compounds, pharmaceutically acceptable salts, hydrates, solvates, clathrates, enantiomers, diastereomers, racemates, or mixtures of stereoisomers thereof, pharmaceutical compositions of these compounds, and methods of using these compounds and compositions in mammals for treatment or prevention of diseases associated with PDE4.

Abstract: An optimal conditional operational schedule for a set of power generators is determined by constructing states and transitions of a factored Markov decision process (fMDP) from a target electrical demand and generator variables. A cost function for the fMDP is constructed based on the electrical demand, the generator variables, and a risk coefficient. Then, the fMDP is solved to obtain the optimal conditional operational schedule.

Abstract: Provided are 4?-arylmethoxy isoindoline compounds, and pharmaceutically acceptable salts, solvates, clathrates, stereoisomers, and prodrugs thereof. Methods of use, and pharmaceutical compositions of these compounds are disclosed.

Abstract: The invention encompasses novel compounds, pharmaceutically acceptable salts, hydrates, solvates, clathrates, enantiomers, diastereomers, racemates, or mixtures of stereoisomers thereof, pharmaceutical compositions of these compounds, and methods of using these compounds and compositions in mammals for treatment or prevention of diseases associated with PDE4.

Abstract: The invention encompasses novel compounds, pharmaceutically acceptable salts, hydrates, solvates, clathrates, enantiomers, diastereomers, racemates, or mixtures of stereoisomers thereof, pharmaceutical compositions of these compounds, and methods of using these compounds and compositions in mammals for treatment or prevention of diseases associated with PDE4.

Abstract: The invention encompasses 7-amido-isoindolyl compounds and methods of using these compounds and compositions in mammals for treatment, prevention or management of various diseases and disorders. Examples include, but are not limited to, cancer, inflammatory bowel disease and myelodysplastic syndrome.

Abstract: The invention encompasses novel compounds, pharmaceutically acceptable salts, hydrates, solvates, clathrates, enantiomers, diastereomers, racemates, or mixtures of stereoisomers thereof, pharmaceutical compositions of these compounds, and methods of using these compounds and compositions in mammals for treatment or prevention of diseases associated with PDE4.

Abstract: The invention encompasses 7-amido-isoindolyl compounds and methods of using these compounds and compositions in mammals for treatment, prevention or management of various diseases and disorders. Examples include, but are not limited to, cancer, inflammatory bowel disease and myelodysplastic syndrome.